13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$342.83B
−6.7% on the quarter before
Positions
433
21 new · 25 sold out
Top 10
25.9%
of the value
Est. gain
−$21.96B
on stocks held all quarter
Est. return
−6.3%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 41% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bristol-Myers Squibb Co~$1.02BAdded · 0.8% → 1.1%+14,298,520 shares
- Jpmorgan Chase & Co~$1.01BAdded · 0.9% → 1.2%+9,702,742 shares
- Equinix~$771.6MAdded · 0.4% → 0.6%+1,356,837 shares
- Wells Fargo Co New~$700.3MAdded · 0.1% → 0.3%+17,411,935 shares
- CenterPoint Energy~$526.8MAdded · 0.4% → 0.6%+18,689,025 shares
- General Electric Co~$516.6MNew · 0.0% → 0.2%+8,343,758 shares
- Gallagher Arthur J & Co~$514.6MAdded · 0.3% → 0.5%+3,005,709 shares
- Jacobs Solutions Inc~$439.5MNew · 0.0% → 0.1%+4,051,189 shares
- Nutrien Ltd~$420.8MAdded · 0.2% → 0.3%+5,045,961 shares
- Albemarle Corp~$418.0MAdded · 0.2% → 0.4%+1,580,772 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Discover Finl Svcs~$833.5MCut · 0.4% → 0.2%−9,167,459 shares
- Gsk Plc~$830.9MSold out · 0.2% → 0.0%−19,087,689 shares
- Exelon Corporation~$742.7MCut · 0.4% → 0.1%−19,822,704 shares
- Fidelity Natl Information Sv~$736.1MCut · 0.9% → 0.5%−9,739,602 shares
- Lyondellbasell Industries N~$693.0MCut · 0.5% → 0.3%−9,206,269 shares
- Pnc Finl Svcs Group Inc~$644.8MCut · 0.3% → 0.1%−4,315,338 shares
- Broadcom~$608.5MSold out · 0.2% → 0.0%−404,794 shares
- Intel~$534.4MCut · 0.9% → 0.5%−20,736,960 shares
- Jacobs Solutions~$514.9MSold out · 0.1% → 0.0%−4,050,337 shares
- Keycorp~$512.4MCut · 0.4% → 0.2%−31,985,428 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.2% · price −9.3% | 5.8% | $19.80B | −$2.03B | ||||||||
| BroadcomCOM · shares +1.9% · price −8.6% | 3.9% | $13.21B | −$1.22B | ||||||||
| Unitedhealth Group IncCOM · shares −1.4% · price −1.7% | 2.6% | $9.03B | −$153.2M | ||||||||
| AmazonCOM · shares −2.3% · price +6.4% | 2.4% | $8.24B | +$494.8M | ||||||||
| AlphabetCAP STK CL C · shares +1.5% · price −12.1% | 2.2% | $7.41B | −$1.00B | ||||||||
| Philip Morris Intl IncCOM · shares +1.6% · price −15.9% | 2.0% | $6.87B | −$1.28B | ||||||||
| MetaCL A · shares −7.6% · price −15.9% | 1.8% | $6.21B | −$1.17B | ||||||||
| Abbvie IncCOM · shares +6.2% · price −12.4% | 1.8% | $6.15B | −$817.4M | ||||||||
| Comcast Corp NewCL A · shares −0.9% · price −25.2% | 1.8% | $6.02B | −$2.03B | ||||||||
| Northrop Grumman CorpCOM · shares −0.4% · price −1.7% | 1.7% | $5.75B | −$98.7M | ||||||||
| Abbott LabsCOM · shares +3.4% · price −10.9% | 1.5% | $5.05B | −$600.4M | ||||||||
| MastercardCL A · shares +3.3% · price −9.9% | 1.4% | $4.78B | −$506.9M | ||||||||
| ConocophillipsCOM · shares −4.3% · price +13.9% | 1.3% | $4.44B | +$543.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares +32% · price −7.2% | 1.2% | $4.20B | −$247.7M | ||||||||
| Raytheon Technologies CorpCOM · shares +9.0% · price −14.8% | 1.1% | $3.90B | −$622.2M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +38% · price −7.7% | 1.1% | $3.73B | −$225.2M | ||||||||
| Chubb LimitedCOM · shares +0.2% · price −7.5% | 1.1% | $3.67B | −$294.9M | ||||||||
| Transdigm Group IncCOM · shares +0.10% · price −2.2% | 1.0% | $3.43B | −$77.1M | ||||||||
| Eog Res IncCOM · shares −3.3% · price +1.1% | 0.99% | $3.41B | +$38.7M | ||||||||
| NetflixCOM · shares +4.2% · price +34.6% | 0.99% | $3.38B | +$834.4M | ||||||||
| AppleCOM · shares +0.8% · price +1.1% | 0.96% | $3.29B | +$35.7M | ||||||||
| Chevron Corp NewCOM · shares +2.6% · price −0.8% | 0.94% | $3.22B | −$24.7M | ||||||||
| AlphabetCAP STK CL A · shares −0.8% · price −7.8% | 0.90% | $3.09B | −$262.4M | ||||||||
| Johnson & JohnsonCOM · shares −3.7% · price −8.0% | 0.90% | $3.07B | −$265.7M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −1.4% · price −3.8% | 0.89% | $3.05B | −$121.0M | ||||||||
| Total · 433 positions | 100% | $342.83B | −$21.96B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 411 stocks held throughout, down $21.96B (−6.3%).
- Netflix+$834.4M+35%
- Constellation Energy Corp+$596.6M+45%
- Conocophillips+$543.4M+14%
- Amazon+$494.8M+6%
- Wolfspeed+$412.3M+63%
- Broadcom−$1.22B−9%
- Philip Morris Intl Inc−$1.28B−16%
- Charter Communications Inc N−$1.34B−35%
- Microsoft−$2.03B−9%
- Comcast Corp New−$2.03B−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |